GI & Endoscopy

Recently, with the FDA approval of Allergan's Viberzi and Valeant Pharmaceuticals' Xifaxan, as well as the low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet, there have been more alternatives available to people suffering from irritable bowel syndrome, according to…

David T. Rubin, MD, is a gastroenterologist and chief of the section of gastroenterology, hepatology and nutrition at the University of Chicago. He is also the Joseph B. Kirsner Professor of Medicine.

Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of April 25 to April 29.

The American Academy of Arts and Sciences elected John D. Carethers, MD, as a member, according to an AGA report.

Tobira Therapeutics announced results from a 12-week interim analysis of the Phase 2a ORION study.

EndoChoice appointed William Enquist as chairman of the board of directors.

A study published in the Journal of Pediatric Gastroenterology and Nutrition found newborns are likely being over treated the majority of the time with interventions, including surgery, for gastroesophageal reflux disease.

Anthony J. DiMarino Jr., MD, is a gastroenterologist and chief of the division of gastroenterology and hepatology at Thomas Jefferson University in Philadelphia. He is also director of TJU's Digestive Disease Institute and is a William Rorer Professor of Medicine.

Here are six gastroenterologists who recently made headlines.

Michael Phalen, acting executive vice president and president-MedSurg of Boston Scientific, recently sold 35,000 shares of the firm, according to a Franklin Independent report.